Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council…
The International Psoriasis Council (IPC) and the National Psoriasis Foundation (NPC) have released a joint position…
The International Psoriasis Council (IPC) and the National Psoriasis Foundation (NPC) have released a joint position…
View ReportEarly and effective treatment in psoriasis mitigates cumulative chronic disease burden and may prevent psoriatic…
View ReportIPC’s Disease Severity Working Group has refined the criteria for mild, moderate, and severe psoriasis based on the…
View ReportA new study reveals systemic inflammation mediates the link between psoriasis severity and cardiovascular disease,…
View ReportThe International Psoriasis Council (IPC) joined IFPA and regional leaders at the IFPA Forum Americas in Bogotá to…
Read MoreThe IPC's global network of experts volunteers annually to educate and train physicians, improving care for individuals…
Read MoreDr. Tiago Torres examines palmoplantar and nail psoriasis and further investigates the treatment options and therapies…
Watch VideoThe program chair and faculty address questions from IPC Global Webinar 3: "The Full Cycle of Psoriasis Care in 2024:…
Watch VideoThe 33rd Annual EADV Congress in Amsterdam featured updates on psoriasis care, including highlights from the IPC…
Read MoreThis report from the 53rd Annual ESDR Meeting in Lisbon covers key presentations on psoriasis, including updates from…
Read MoreIPC GLOBAL WEBINAR SERIES Program chairs: Curdin Conrad, Switzerland Program faculty: Cristina Echeverría, Argentina…
EUROPEAN SOCIETY FOR DERMATOLOGICAL RESEARCH ANNUAL MEETING (ESDR) | LISBON, PORTUGAL Program chairs: Johann…
Gain expert insights into two recent publications shedding light on the molecular mechanisms of IL-23/IL-17…
Read MoreACADEMIA ESPAÑOLA DE DERMATOLOGÍA Y VENEREOLOGÍA (AEDV) CONGRESS | MADRID, SPAIN Thursday, January 18 18:00 -…
PHILIPPINES PSORIASIS SYMPOSIUM | VIRTUAL Thursday, October 5 12:00-14:15 CEST 6:00-08:15 EDT 18:00-20:15…
The prognosis and maintenance of response after treatment discontinuation following remission lack proper…
Read MoreThe European Academy of Dermatology and Venereology (EADV) organized its 31st congress in Milano, Italy, under the…
Read MoreLa psoriasis y la tuberculosis han ido de la mano durante mucho tiempo. Esto es especialmente cierto en ciertas partes…
View ReportA psoríase e a tuberculose há muito andam de mãos dadas. Isto é especialmente verdade em certas partes do mundo,…
Read MoreLa psoriasis y la tuberculosis han ido de la mano durante mucho tiempo. Esto es especialmente cierto en ciertas partes…
Read More| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.
PRE-ORDER YOUR COPY
In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.
IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.